Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent disease

BACKGROUND: Patients who develop oligorecurrent disease may be treated with metastasis-directed stereotactic body radiotherapy (SBRT) to defer the start of systemic therapy and delay its potential side effects. We report oncological outcomes and patterns of failure in patients with oligorecurrent di...

Descripción completa

Detalles Bibliográficos
Autores principales: Willmann, Jonas, Vlaskou Badra, Eugenia, Adilovic, Selma, Christ, Sebastian M., Ahmadsei, Maiwand, Mayinger, Michael, Guckenberger, Matthias, Andratschke, Nicolaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421088/
https://www.ncbi.nlm.nih.gov/pubmed/36046333
http://dx.doi.org/10.1016/j.ctro.2022.08.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421088/
https://www.ncbi.nlm.nih.gov/pubmed/36046333
http://dx.doi.org/10.1016/j.ctro.2022.08.008

Ejemplares similares